C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells

International Journal of Cancer

Volumn 99, Issue 1, 2002, Pages 35-42

  Venditti, Marcello ^a   Iwasiow, Barbara ^a   Orr, F William ^a   Shiu, Robert P C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antiestrogen; Breast; C myc; Cancer; Proliferation; Tetracycline

Indexed keywords

ANTIESTROGEN; CASPASE; DOXYCYCLINE; ESTRADIOL; FULVESTRANT; LUCIFERASE; MESSENGER RNA; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL LINE; CELL STRAIN MCF 7; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION; GENES, MYC; HUMANS; LUCIFERASES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036568506     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10269     Document Type: Article

References (50)

1. Myc function and regulation
2. Proteins of the Myc network: Essential regulators of cell growth and differentiation
3. c-Myc target genes involved in cell growth, apoptosis and metabolism
4. Mouse models for breast cancer
5. Defining a role for c-Myc in breast tumorigenesis
6. c-Myc in breast cancer
7. C-myc amplification in breast cancer: A meta-analysis of its occurrence and prognostic relevance
8. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
9. BRCA1 binds c-myc and inhibits its transcriptional and transforming activity in cells
10. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotides identifies a critical role for c-myc in growth of human breast cancer
11. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells
12. Mechanism of estrogen activation of c-myc oncogene expression
13. Estrogen and c-myc protooncogene actions in human breast cancer
14. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
15. Hormonal therapy for breast cancer. An update
16. Cellular and molecular pharmacology of antiestrogen action and resistance
17. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182,780 in women with advanced breast cancer
18. Comparison between novel steroid-like and conventional nonsteroidal antiestrogens in inhibiting estradiol- and IGF-l-induced proliferation of human breast cancer-derived cells
19. Transcriptional activation by tetracycline in mammalian cells
20. A non-AUG translational initiation in c-myc exon 1 generates an N-terminal distinct protein whose synthesis is disrupted in Burkitt lymphomas
21. Myc and Max homologs in Drosophila
22. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis
23. Distinct domains of recombinant human IFN-γ responsible for anti-viral effector function
24. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
25. Effect of estradiol on human breast cancer cells in culture
26. Myc and Max associate in vivo
27. The many roles of c-Myc in apoptosis
28. Mechanisms of apoptosis by c-Myc
29. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
30. Cleavage of automodified poly (ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7
31. Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus
32. New concepts in steroid hormone action: Transcription factors, proto-oncogenes and the cascade model for steroid regulation of gene expression
33. 1 mimics the estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry
34. Effects of doxycycline on cancer cells in vitro and in vivo
35. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone- metastasizing cancer cells
36. Losses of the tumor suppressor B1N1 in breast carcinoma frequent and reflect deficits in programmed cell death capacity
37. Binl mediates apoptosis by c-Myc in transformed primary cells
38. Apoptosis induced by c-myc expression is dependent on growth conditions
39. Induction of apoptosis in fibroblasts by c-myc protein
40. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and downregulation of BCL-2 than tamoxifen in MCF-7 cells
41. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line
42. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780
43. Antiestrogen inhibition of cell cycle progression in breast cancer cells associated with inhibition of cyclin- dependent kinase activity and decreased retinoblastoma protein phosphorylation
44. 1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
45. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term culture
46. Optimization of estrogen growth response in MCF-7 cells
47. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways
48. Insulin-like growth factors in human breast cancer
49. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells